GlassScriptPhysician profile
Charles C Giger
NPI 1275558496
$5,122.87
in general payments reported to CMS, 2019-2025
17 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,098 · 2020: $544 · 2021: $11.38 · 2022: $242 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,914.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $723.12 | 2019-2025 | Breztri, Farxiga |
| Novo Nordisk INC | $392.63 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.38 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $365.41 | 2019 | |
| Lilly USA, LLC | $330.85 | 2019-2020 | |
| Glaxosmithkline, LLC. | $320.77 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $152.44 | 2019 | |
| Pfizer INC. | $145.17 | 2019 | |
| Sanofi-Aventis U.S. LLC | $124.24 | 2019 | |
| Amgen INC. | $71.20 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $50.81 | 2019-2020 | |
| Allergan, INC. | $45.63 | 2019 | |
| Merck Sharp & Dohme LLC | $42.72 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $18.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.27 | 2019 | |
| Hikma Pharmaceuticals USA | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Giger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.